Aaron E. Alt is CFO at CARDINAL HEALTH INC (CAH). They have made 13 open-market trades across 4 companies since 2018, most recently 2026-08-25.
CIK 0001741576
9 open-market purchases totalling $598K since 2018, against 4 sales. Across 8 scored buys the stock is up 8.1% at ninety days, and 4.1 points ahead of the S&P over the same stretch.
9 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CAH | 20,495 | $5.2M |
| SYY | 37,166 | $3.1M |
| SBH | 98,853 | $1.6M |
| KDP | 7,862 | $272K |
| Total | $10.2M |
Shares reported on the most recent Form 4, priced at the 2026-08-27 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 11% | 44% | 38% |
| Avg Move | -3.6% | -2.1% | +8.1% |
| Alpha | -2.3% | -3.1% | +4.1% |
| Scored | 9 | 9 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KDP | BUY | 2026-08-25 | 2026-08-27 | $31.83 | $250K | -0.1% | -2.1% | — |
| CAH | SELL | 2026-08-18 | 2026-08-20 | $236.34 | $9.9M | +4.1% | -1.7% | — |
| CAH | SELL | 2026-02-18 | 2026-02-18 | $225.50 | $525K | +2.2% | -7.6% | -10.9% |
| CAH | SELL | 2025-08-19 | 2025-08-19 | $148.78 | $14.4M | -0.4% | +0.4% | +38.0% |
| CAH | SELL | 2024-08-19 | 2024-08-19 | $108.91 | $506K | +2.3% | +1.6% | +9.4% |
| SYY | BUY | 2022-06-21 | 2022-06-22 | $80.09 | $80K | +6.6% | +8.7% | -0.5% |
| SBH | BUY | 2020-03-06 | 2020-03-09 | $11.87 | $24K | -18.7% | -25.5% | +32.5% |
| SBH | BUY | 2019-08-21 | 2019-08-21 | $12.27 | $12K | -5.7% | +14.1% | +48.6% |
| SBH | BUY | 2019-05-31 | 2019-05-31 | $14.93 | $22K | -3.1% | -17.6% | -14.3% |
| SBH | BUY | 2019-02-14 | 2019-02-15 | $18.66 | $50K | -3.3% | -2.9% | -13.3% |
| SBH | BUY | 2018-11-13 | 2018-11-13 | $20.75 | $50K | -4.8% | -10.6% | -13.0% |
| SBH | BUY | 2018-08-06 | 2018-08-06 | $14.07 | $56K | -0.6% | +12.2% | +29.7% |
| SBH | BUY | 2018-05-22 | 2018-05-24 | $15.10 | $53K | -2.7% | +4.7% | -5.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.